Biosimilars Council   Leading on Biosimilars for Americas Patients @accessiblemeds
Biosimilars Council   Leading on Biosimilars for Americas Patients  @accessiblemeds
Uploaded February 2022 | Updated November 2026, 3 hours ago
The Biosimilars Council, a division of the Association for Accessible Medicines, works to increase patient access to lifesaving, affordable biosimilar medicines. Leveraging our deep relationships on Capitol Hill, in federal agencies like FDA and CMS, and in the states, we strive to create a positive regulatory, reimbursement, political and policy environment to assure biosimilars thrive, providing billions in savings to patients and the health care system. Our members include biosimilar manufacturers and stakeholders working to promote biosimilar products in the U.S. market.

Learn more at: biosimilarscouncil.org
Biosimilars Council   Leading on Biosimilars for Americas PatientsSeniors Paying Billions More Than They Should — #DoesntAddUpGeneric Medicines 35th Birthday CelebrationGRx+Biosims 2020 ExpoJoin us at Access! 2026Access! 2019 Day 1 RecapInter Partes Review Process (IPR) - Explainer VideoThe CREATES Act - A Conservative, Market-based Solution to Lower Drug PricesWhat is a Biosimilar?Access! 2019: Charting a Path for the FutureKeons StoryAriels Story - Cancer Thriver!
Association for Accessible Medicines |

Biosimilars Council -- Leading on Biosimilars for America's Patients

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER